Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel®: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|7|3|673-680

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.3, 2014-09, pp. : 673-680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Disease Control of a Non-Operable Neuroendocrine Tumor of the Lung with Lanreotide: A Case Study

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 657-666

Karger

Access to resources Recommend Favorite

Efficacy and Long-Term Safety of Everolimus in Pancreatic Neuroendocrine Tumor Associated with Multiple Endocrine Neoplasia Type I: Case Report

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 643-645

Karger

Access to resources Recommend Favorite

Lanreotide Autogel®® in acromegaly and neuroendocrine tumors

By Caron Philippe  

Therapy, Vol. 4, Iss. 1, 2007-01 ,pp. : 9-29

Future Medicine

Access to resources Recommend Favorite

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 155-163

Karger

Access to resources Recommend Favorite

Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-04 ,pp. : 189-195

Karger

Access to resources Recommend Favorite